Skip to main content
DNA Labs India

Immunohistochemistry GATA-3 Test

DNA Labs India | ISO 9001:2015 Certified

Immunohistochemistry GATA-3 Test

Short Name: IHC GATA-3

Also known as: GATA-3 Immunohistochemistry, GATA-3 IHC Staining, GATA-3 Protein Expression Test, GATA-3 Tumor Marker Test

Immunohistochemistry GATA-3 Test test available at DNA Labs India for ₹3,500. Uses Immunohistochemistry (IHC) on Tumor tissue in 10% Formal-saline or Formalin Fixed Paraffin Embedded (FFPE) block samples. Results in Sample Daily by 6 pm; Report – Block: 5 days, Tissue Biopsy: 5 days, Large Complex Tissue: 7 days. Free home collection in 300+ cities across India.

Immunohistochemistry🏠 Home Collection

🩺 Medically Reviewed By

Overview

The primary purpose of the Immunohistochemistry GATA-3 Test is to identify GATA-3 protein expression in tumour tissue, which aids in the diagnosis and subtyping of mammary carcinoma and urothelial carcinoma. This marker helps pathologists confirm the tissue of origin when cancer has spread (metastasised) to distant sites, distinguish breast cancer from other adenocarcinomas, and support the differential diagnosis of bladder tumours. The test may also be used as part of a broader immunohistochemical panel in the workup of certain lymphomas and other neoplasms.

Test Code
996
CPT Code
88342
ICD Code
C50, C67
Price
₹3,500
Sample Type
Tumor tissue in 10% Formal-saline or Formalin Fixed Paraffin Embedded (FFPE) block
Result Time
Sample Daily by 6 pm; Report – Block: 5 days, Tissue Biopsy: 5 days, Large Complex Tissue: 7 days
Fasting Required
No
Method
Immunohistochemistry (IHC)
Step 1

Sample Collection

No special patient preparation is required. The test is performed on an already collected tissue specimen. A copy of the histopathology report, site of biopsy, and relevant clinical history must accompany the specimen.

Method: Tissue biopsy or surgical resection specimen

Step 2

Laboratory Analysis

Tissue is collected via core needle biopsy, incisional biopsy, excisional biopsy, or surgical resection by the treating physician. This is a laboratory-side test and does not involve a separate patient-side collection procedure.

Step 3

Report Delivery

The tissue specimen is fixed in 10% formal-saline or processed into a formalin-fixed paraffin-embedded (FFPE) block. It is then sent to the histopathology lab for GATA-3 immunohistochemical staining and interpretation.

Timeline: Sample Daily by 6 pm; Report – Block: 5 days, Tissue Biopsy: 5 days, Large Complex Tissue: 7 days

Patient Instructions

1
Before the Test:No specific patient-side preparation is required. The test is performed on a previously collected tissue specimen submitted by the referring physician.
2
During the Test:The laboratory processes the tissue specimen through immunohistochemical staining using anti-GATA-3 antibodies. A pathologist examines the stained slides under a microscope to evaluate staining pattern, intensity, and percentage of positive cells.
3
After the Test:After evaluation, the pathologist issues a structured report detailing the GATA-3 staining results, which is shared with the referring physician. Discuss the results with your oncologist to understand their significance in the context of your overall diagnosis and treatment plan.

About This Test

Who Should Get This Test

The primary purpose of the Immunohistochemistry GATA-3 Test is to identify GATA-3 protein expression in tumour tissue, which aids in the diagnosis and subtyping of mammary carcinoma and urothelial carcinoma. This marker helps pathologists confirm the tissue of origin when cancer has spread (metastasised) to distant sites, distinguish breast cancer from other adenocarcinomas, and support the differential diagnosis of bladder tumours. The test may also be used as part of a broader immunohistochemical panel in the workup of certain lymphomas and other neoplasms.

How to Prepare

  • Submit tumour tissue in 10% Formal-saline or as a Formalin Fixed Paraffin Embedded (FFPE) block
  • Ship the specimen at room temperature
  • Provide a copy of the histopathology report along with the specimen
  • Include the site of biopsy and detailed clinical history on the requisition form
  • Ensure the specimen is properly labelled with patient identification details

Doctor's Notes

Reviewed by — MBBS, MD (Pathology) · Reg. No. 21521

"GATA-3 immunohistochemistry is a valuable diagnostic marker in routine oncology practice. Its strong nuclear expression is characteristic of mammary and urothelial carcinomas, helping pathologists confirm the primary site of a tumour and differentiate it from other carcinoma subtypes. A positive GATA-3 result, in the appropriate morphological context, supports a breast or bladder origin and guides further treatment planning. Patients should always discuss IHC results with their treating oncologist for comprehensive management."

Last medically reviewed: September 7, 2026

Test Parameters & Specifications

Sample TypeTumor tissue in 10% Formal-saline or Formalin Fixed Paraffin Embedded (FFPE) block
Sample VolumeAs per tissue block size
Container10% Formal-saline container or FFPE block
Collection MethodTissue biopsy or surgical resection specimen

Sample Stability

FFPE Block at Room Temperature
Formalin-fixed tissue at Room Temperature
Unfixed tissue
Sample Rejection Criteria:
  • Unlabelled or mislabelled specimen
  • Specimen received without formalin fixation and beyond acceptable cold ischemia time
  • Inadequate tumour tissue for evaluation
  • Specimen without accompanying histopathology report or clinical history
  • Severely autolysed or necrotic tissue yielding non-diagnostic staining

Understanding Your Results

GATA-3 immunohistochemistry results are interpreted by a qualified pathologist in the context of tumour morphology, clinical presentation, and other ancillary immunohistochemical markers. The following guide provides a general framework for understanding GATA-3 results:
📊

GATA-3 Strongly Positive (Diffuse Nuclear Staining)

Strong and diffuse nuclear GATA-3 expression is highly suggestive of mammary carcinoma (particularly luminal subtypes) or urothelial carcinoma. Clinical and morphological correlation is recommended.

📊

GATA-3 Weakly or Focally Positive

Weak or focal GATA-3 staining may be seen in certain subtypes of breast cancer, some urothelial tumours, or other GATA-3-expressing neoplasms. Additional immunohistochemical markers are recommended for definitive classification.

📊

GATA-3 Negative

Absence of GATA-3 staining does not entirely exclude breast or urothelial origin, particularly in triple-negative breast cancers or high-grade urothelial carcinomas that may lose GATA-3 expression. A broader immunohistochemical panel should be evaluated.

⚠️ When to Consult a Doctor:

Consult your oncologist or treating physician if your GATA-3 test result is abnormal, equivocal, or if the result does not correlate with clinical findings. Additional immunohistochemical studies or molecular tests may be recommended to establish a definitive diagnosis and guide treatment planning.

Limitations

  • GATA-3 is not entirely specific for breast or urothelial cancer; it can also be expressed in some T-cell lymphomas, trophoblastic tumours, salivary gland tumours, and a subset of squamous cell carcinomas
  • Negative GATA-3 staining does not exclude breast or bladder cancer, as some subtypes (e.g., triple-negative breast cancer) may lose GATA-3 expression
  • This test should be interpreted as part of a panel and not as a standalone diagnostic marker
  • Interpretation requires correlation with morphological features, clinical history, and additional immunohistochemical stains

Risks & Considerations

  • As this test is performed on an already collected tissue specimen, there are no additional procedural risks to the patient
  • Risks associated with the original biopsy or surgical procedure are managed by the treating clinical team

Interfering Factors

  • Prolonged fixation or under-fixation of tissue may affect antigen preservation and staining quality
  • Decalcification of bone tissue specimens can degrade GATA-3 antigenicity
  • Necrotic or heavily haemorrhagic tissue areas may yield non-specific or uninterpretable staining
  • Use of certain fixatives other than formalin may impair immunoreactivity

Compare With Similar Tests

TestImmunohistochemistry GATA-3 TestIHC ER (Estrogen Receptor)IHC HER2/neuIHC CK20IHC p63
ComparisonImmunohistochemistry GATA-3 Test

Frequently Asked Questions

What is the Immunohistochemistry GATA-3 Test?
The Immunohistochemistry GATA-3 Test is a laboratory-based pathology test that detects the presence of GATA-3 protein in tumour tissue using immunohistochemical staining. It helps identify whether a cancer originated in the breast or urinary bladder and is widely used by pathologists in tumour diagnosis and subtyping.
Why is the GATA-3 IHC test ordered?
This test is ordered by an oncologist or pathologist to confirm the tissue of origin of a tumour, particularly when breast cancer or urothelial carcinoma of the bladder is suspected. It is also used to evaluate metastatic carcinomas of unknown primary origin and as part of a broader immunohistochemical panel.
What sample is required for the GATA-3 test?
The test requires a tumour tissue sample submitted either in 10% formal-saline or as a formalin-fixed paraffin-embedded (FFPE) block. The sample is typically obtained through a biopsy or surgical resection procedure performed by your treating physician.
What does a positive GATA-3 result mean?
A positive GATA-3 result indicates that the tumour cells express GATA-3 protein, which is characteristic of mammary carcinoma (breast cancer) and urothelial carcinoma (bladder cancer). However, the result must always be interpreted alongside morphological findings, clinical history, and other immunohistochemical markers by a qualified pathologist.
What does a negative GATA-3 result mean?
A negative GATA-3 result means that GATA-3 protein expression was not detected in the tumour tissue. This does not completely exclude breast or bladder cancer, as certain subtypes such as triple-negative breast cancer or high-grade urothelial carcinomas may not express GATA-3. Additional immunohistochemical markers may be recommended.
What is the cost of the Immunohistochemistry GATA-3 Test at DNA Labs India?
The Immunohistochemistry GATA-3 Test at DNA Labs India is priced at INR 3500. This cost includes tissue processing, immunohistochemical staining, pathologist interpretation, and digital report delivery.
Is the GATA-3 test painful?
The GATA-3 test itself is not a separate procedure. It is performed on a tissue sample that has already been collected via biopsy or surgery. Any discomfort or pain is related to the original biopsy procedure and is managed by your clinical team.
How long does it take to get GATA-3 test results?
The turnaround time for the Immunohistochemistry GATA-3 Test is typically 5 working days for standard tissue biopsies and FFPE blocks. Large or complex tissue specimens may require up to 7 working days. Reports are delivered via online portal, email, or WhatsApp.
Is home sample collection available for the GATA-3 test?
Yes, DNA Labs India offers free home sample collection for the Immunohistochemistry GATA-3 Test across many cities in India. You can book online and schedule a convenient time for collection. The service is available in major cities including Mumbai, Delhi, Bangalore, Hyderabad, Chennai, Kolkata, and many more.
Can GATA-3 be used to detect cancers other than breast and bladder cancer?
While GATA-3 is primarily used as a marker for mammary and urothelial carcinomas, it can also be expressed in certain T-cell lymphomas, trophoblastic tumours, and some salivary gland neoplasms. Its expression in these tumours is interpreted within the broader clinical and pathological context.
Do I need to fast before the GATA-3 test?
No, fasting is not required for the Immunohistochemistry GATA-3 Test. The test is performed on an already collected tissue specimen, and no special patient preparation is needed on the day of laboratory analysis.
Is the GATA-3 IHC test covered by insurance?
Insurance coverage for the Immunohistochemistry GATA-3 Test depends on your individual policy and the scheme you are enrolled in. Government schemes such as PMJAY, CGHS, ECHS, and ESIC may cover diagnostic tests under specific conditions. We recommend verifying coverage with your insurance provider or scheme authority before booking.
Worried about the process? Our certified phlebotomists collect thousands of samples every month across India. The process takes under 5 minutes and is virtually painless. Questions? Message us on WhatsApp — we're here 7 days a week.

Related Tests

For Hospitals & Clinics

Reference Laboratory Services

We serve as a reference laboratory for hospitals and clinics across India. Send samples from your facility with same-day pickup, priority processing, and results delivered through our online portal. Competitive institutional pricing available.

LIMS Integration

Your Data Privacy

Your medical data is protected under Indian law.

Stored in India: All patient records are stored on servers located in India. No data is transferred outside the country.

DPDP Act Compliant: Under the Digital Personal Data Protection Act 2023, you can request deletion of your records at any time by contacting support.

Book Your Test

Enter your details and we'll connect you within 15 minutes.

🧬

Quick Connect

Enter your mobile number and we’ll connect you with the team.

+91

✅ Connecting you now...

🔒 Your number is used to respond to this request.